• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在单残基分辨率下对内在无序蛋白tau进行蛋白酶体降解

Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution.

作者信息

Ukmar-Godec T, Fang P, Ibáñez de Opakua A, Henneberg F, Godec A, Pan K-T, Cima-Omori M-S, Chari A, Mandelkow E, Urlaub H, Zweckstetter M

机构信息

German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075 Göttingen, Germany.

Department of Neurology, University Medical Center Göttingen, University of Göttingen, Waldweg 33, 37073 Göttingen, Germany.

出版信息

Sci Adv. 2020 Jul 22;6(30):eaba3916. doi: 10.1126/sciadv.aba3916. eCollection 2020 Jul.

DOI:10.1126/sciadv.aba3916
PMID:32832664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7439447/
Abstract

Intrinsically disordered proteins (IDPs) can be degraded in a ubiquitin-independent process by the 20 proteasome. Decline in 20 activity characterizes neurodegenerative diseases. Here, we examine 20 degradation of IDP tau, a protein that aggregates into insoluble deposits in Alzheimer's disease. We show that cleavage of tau by the 20 proteasome is most efficient within the aggregation-prone repeat region of tau and generates both short, aggregation-deficient peptides and two long fragments containing residues 1 to 251 and 1 to 218. Phosphorylation of tau by the non-proline-directed Ca/calmodulin-dependent protein kinase II inhibits degradation by the 20 proteasome. Phosphorylation of tau by GSK3β, a major proline-directed tau kinase, modulates tau degradation kinetics in a residue-specific manner. The study provides detailed insights into the degradation products of tau generated by the 20 proteasome, the residue specificity of degradation, single-residue degradation kinetics, and their regulation by posttranslational modification.

摘要

内在无序蛋白(IDP)可通过20S蛋白酶体在不依赖泛素的过程中被降解。20S活性下降是神经退行性疾病的特征。在此,我们研究IDP tau的20S降解情况,tau蛋白在阿尔茨海默病中会聚集形成不溶性沉积物。我们发现,20S蛋白酶体对tau的切割在tau易于聚集的重复区域内最为有效,并产生短的、缺乏聚集能力的肽段以及两个包含1至251位残基和1至218位残基的长片段。非脯氨酸定向的钙/钙调蛋白依赖性蛋白激酶II对tau的磷酸化会抑制20S蛋白酶体的降解作用。糖原合成酶激酶3β(一种主要的脯氨酸定向tau激酶)对tau的磷酸化以残基特异性方式调节tau的降解动力学。该研究详细深入地探讨了20S蛋白酶体产生的tau降解产物、降解的残基特异性、单残基降解动力学以及它们通过翻译后修饰的调控情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/a5b14ef107e7/aba3916-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/59aaebe5b15f/aba3916-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/ae26806eca30/aba3916-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/fbecaa908910/aba3916-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/20e9908ce2c2/aba3916-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/6690bfd05486/aba3916-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/a5b14ef107e7/aba3916-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/59aaebe5b15f/aba3916-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/ae26806eca30/aba3916-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/fbecaa908910/aba3916-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/20e9908ce2c2/aba3916-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/6690bfd05486/aba3916-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ace4/7439447/a5b14ef107e7/aba3916-F6.jpg

相似文献

1
Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution.在单残基分辨率下对内在无序蛋白tau进行蛋白酶体降解
Sci Adv. 2020 Jul 22;6(30):eaba3916. doi: 10.1126/sciadv.aba3916. eCollection 2020 Jul.
2
Fluspirilene Analogs Activate the 20S Proteasome and Overcome Proteasome Impairment by Intrinsically Disordered Protein Oligomers.氟哌啶醇类似物激活 20S 蛋白酶体并克服由固有无序蛋白质寡聚物引起的蛋白酶体损伤。
ACS Chem Neurosci. 2021 Apr 21;12(8):1438-1448. doi: 10.1021/acschemneuro.1c00099. Epub 2021 Mar 31.
3
The C-Terminus of the PSMA3 Proteasome Subunit Preferentially Traps Intrinsically Disordered Proteins for Degradation.PSMA3 蛋白酶体亚基的 C 端优先捕获固有无序蛋白进行降解。
Cells. 2022 Oct 14;11(20):3231. doi: 10.3390/cells11203231.
4
Syrosingopine Enhances 20S Proteasome Activity and Degradation of α-Synuclein.西洛辛碱增强 20S 蛋白酶体活性和降解 α-突触核蛋白。
J Nat Prod. 2024 Mar 22;87(3):554-559. doi: 10.1021/acs.jnatprod.3c00661. Epub 2023 Nov 8.
5
Reconstitution Assays of 20S Proteasome.20S蛋白酶体的重组分析
Bio Protoc. 2021 Apr 5;11(7):e3967. doi: 10.21769/BioProtoc.3967.
6
Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.瞄准核心:泛素非依赖性 20S 蛋白酶体作为神经退行性疾病药物靶点的适宜性。
Transl Res. 2018 Aug;198:48-57. doi: 10.1016/j.trsl.2018.05.002. Epub 2018 Jun 19.
7
Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration.二氢喹唑啉可增强20S蛋白酶体活性,并诱导α-突触核蛋白降解,α-突触核蛋白是一种与神经退行性变相关的内在无序蛋白。
Bioorg Med Chem Lett. 2021 Mar 15;36:127821. doi: 10.1016/j.bmcl.2021.127821. Epub 2021 Jan 27.
8
The Disordered Landscape of the 20S Proteasome Substrates Reveals Tight Association with Phase Separated Granules.20S 蛋白酶体底物的紊乱景观揭示了与相分离颗粒的紧密关联。
Proteomics. 2018 Nov;18(21-22):e1800076. doi: 10.1002/pmic.201800076. Epub 2018 Aug 8.
9
Disordered Substrates of the 20S Proteasome Link Degradation with Phase Separation.20S 蛋白酶体的无序底物与相分离的降解有关。
Proteomics. 2018 Nov;18(21-22):e1800276. doi: 10.1002/pmic.201800276. Epub 2018 Aug 20.
10
Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.在正常细胞条件下,Tau 蛋白的降解由 ATP/泛素非依赖性 20S 蛋白酶体催化。
Arch Biochem Biophys. 2010 Aug 15;500(2):181-8. doi: 10.1016/j.abb.2010.05.008. Epub 2010 May 15.

引用本文的文献

1
SpectraSage unveils specific proteolytic patterns of 20S on mono-ubiquitylated Tau proteoforms involved in neurodegeneration.SpectraSage揭示了20S对参与神经退行性变的单泛素化Tau蛋白异构体的特定蛋白水解模式。
Chem Sci. 2025 Aug 20. doi: 10.1039/d5sc04240b.
2
Degrons: defining the rules of protein degradation.降解结构域:定义蛋白质降解的规则
Nat Rev Mol Cell Biol. 2025 Jul 14. doi: 10.1038/s41580-025-00870-z.
3
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases.神经退行性疾病中胶质细胞对突触和毒性蛋白的吞噬作用。

本文引用的文献

1
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models.靶向降解额颞叶痴呆患者来源神经元细胞模型中的异常 tau。
Elife. 2019 Mar 25;8:e45457. doi: 10.7554/eLife.45457.
2
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.肝素诱导的 tau 丝是多态的,与阿尔茨海默病和匹克病中的 tau 丝不同。
Elife. 2019 Feb 5;8:e43584. doi: 10.7554/eLife.43584.
3
Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
Mol Neurodegener. 2025 Jul 9;20(1):81. doi: 10.1186/s13024-025-00870-9.
4
Ubiquitin-Proteasome System Dysregulation in Alzheimer's Disease Impacts Protein Abundance.阿尔茨海默病中泛素-蛋白酶体系统失调影响蛋白质丰度。
bioRxiv. 2025 May 29:2025.05.29.656728. doi: 10.1101/2025.05.29.656728.
5
Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase.多个位点及其他位点使tau蛋白成为Fyn激酶SH3结构域的一个适应性粘性表面。
Angew Chem Int Ed Engl. 2025 Jul 7;64(28):e202504292. doi: 10.1002/anie.202504292. Epub 2025 May 23.
6
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
7
Tracking proteasome degradation: A cross-organ analysis via intact degradomics mass spectrometry.追踪蛋白酶体降解:通过完整降解组学质谱法进行的跨器官分析。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2419607122. doi: 10.1073/pnas.2419607122. Epub 2025 Feb 18.
8
GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filaments.糖原合成酶激酶3β磷酸化催化tau聚集成阿尔茨海默病样细丝。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2414176121. doi: 10.1073/pnas.2414176121. Epub 2024 Dec 18.
9
Using temperature coefficients to support resonance assignment of intrinsically disordered proteins.利用温度系数辅助固有无序蛋白质的共振归属。
J Biomol NMR. 2025 Mar;79(1):59-65. doi: 10.1007/s10858-024-00452-9. Epub 2024 Dec 7.
10
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond.以双功能分子进行靶向蛋白质降解作为治疗阿尔茨海默病及其他疾病的新型治疗方式。
Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.
瞄准核心:泛素非依赖性 20S 蛋白酶体作为神经退行性疾病药物靶点的适宜性。
Transl Res. 2018 Aug;198:48-57. doi: 10.1016/j.trsl.2018.05.002. Epub 2018 Jun 19.
4
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.促进衰老相关神经退行性疾病中神经毒性蛋白的清除。
Nat Rev Drug Discov. 2018 Sep;17(9):660-688. doi: 10.1038/nrd.2018.109. Epub 2018 Aug 17.
5
Disordered Substrates of the 20S Proteasome Link Degradation with Phase Separation.20S 蛋白酶体的无序底物与相分离的降解有关。
Proteomics. 2018 Nov;18(21-22):e1800276. doi: 10.1002/pmic.201800276. Epub 2018 Aug 20.
6
The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease.蛋白稳态调控通路在阿尔茨海默病中的新兴作用。
Aging Cell. 2018 Oct;17(5):e12801. doi: 10.1111/acel.12801. Epub 2018 Jul 10.
7
Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.小分子增强20S蛋白酶体活性靶向内在无序蛋白质。
ACS Chem Biol. 2017 Sep 15;12(9):2240-2247. doi: 10.1021/acschembio.7b00489. Epub 2017 Aug 1.
8
Cryo-EM structures of tau filaments from Alzheimer's disease.阿尔茨海默病tau蛋白细丝的冷冻电镜结构
Nature. 2017 Jul 13;547(7662):185-190. doi: 10.1038/nature23002. Epub 2017 Jul 5.
9
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.通过激活环磷酸腺苷-蛋白激酶A信号通路,可在疾病早期预防tau蛋白驱动的26S蛋白酶体损伤和认知功能障碍。
Nat Med. 2016 Jan;22(1):46-53. doi: 10.1038/nm.4011. Epub 2015 Dec 21.
10
Tau in physiology and pathology.tau 在生理学和病理学中的作用。
Nat Rev Neurosci. 2016 Jan;17(1):5-21. doi: 10.1038/nrn.2015.1. Epub 2015 Dec 3.